The purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 subtypes with survival of the IHC surrogates (surrogate classification) within American Joint Commission on Cancer (AJCC) stages 1, 2, and 3. The gene discussed is ESR1; the disease is breast cancer.